Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024. This event, held in Tokyo from 27th to 29th October, brings together global leaders in drug development and regulatory science.

The conference will focus on "Driving Patient-Centric Innovation" and offers a unique opportunity for industry professionals to engage in high-level discussions on the latest advancements in drug development, regulatory trends, and innovative technologies in healthcare.

As an attendee, Dr. Taubel will be contributing to the dialogue on cutting-edge clinical research practices. If you would like to connect with us during the event, please feel free to reach out and arrange a meeting.

For more information about the event, please visit the DIA Japan Annual Meeting 2024 website.

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event